Baolingbao Biology Co.,Ltd. (SHE:002286)
China
· Delayed Price · Currency is CNY 10.17
-0.01 (-0.10%)
Apr 29, 2026, 3:04 PM CST
Baolingbao Biology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Cash & Equivalents | 283.51 | 273.98 | 254.95 | 242.74 | 375.95 | 585.44 | Upgrade
|
| Trading Asset Securities | 2 | 2.8 | - | - | - | 106.67 | Upgrade
|
| Cash & Short-Term Investments | 285.51 | 276.78 | 254.95 | 242.74 | 375.95 | 692.11 | Upgrade
|
| Cash Growth | 1.24% | 8.56% | 5.03% | -35.43% | -45.68% | 42.63% | Upgrade
|
| Accounts Receivable | 331.82 | 271.64 | 245.79 | 241.99 | 238.48 | 284.29 | Upgrade
|
| Other Receivables | 16.96 | 20.84 | 8.06 | 19.25 | 12.32 | 19 | Upgrade
|
| Receivables | 348.78 | 292.48 | 253.85 | 261.24 | 250.8 | 303.29 | Upgrade
|
| Inventory | 324.99 | 321.91 | 288.71 | 278.58 | 335.39 | 285.09 | Upgrade
|
| Prepaid Expenses | - | - | - | - | - | 0.76 | Upgrade
|
| Other Current Assets | 61.43 | 23.14 | 12.71 | 3.31 | 33.64 | 33.63 | Upgrade
|
| Total Current Assets | 1,021 | 914.3 | 810.22 | 785.87 | 995.78 | 1,315 | Upgrade
|
| Property, Plant & Equipment | 1,505 | 1,473 | 1,454 | 1,433 | 1,532 | 1,286 | Upgrade
|
| Long-Term Investments | 221.49 | 215.47 | 246.92 | 286.16 | 323.53 | 268.14 | Upgrade
|
| Other Intangible Assets | 113.78 | 114.11 | 117.5 | 121.28 | 125.07 | 129.27 | Upgrade
|
| Long-Term Deferred Tax Assets | 17.19 | 15.89 | 10.31 | 5.58 | 4.16 | 3.32 | Upgrade
|
| Long-Term Deferred Charges | 29.01 | 26.13 | 22.38 | 20.42 | 18.68 | 12.14 | Upgrade
|
| Other Long-Term Assets | 21.31 | 22.73 | 12.21 | 6.91 | 6.65 | 14.89 | Upgrade
|
| Total Assets | 2,928 | 2,781 | 2,674 | 2,659 | 3,006 | 3,029 | Upgrade
|
| Accounts Payable | 228.12 | 227.21 | 213.11 | 237.56 | 314.16 | 634.38 | Upgrade
|
| Accrued Expenses | 24.42 | 35.84 | 39.12 | 32.84 | 38.54 | 42.22 | Upgrade
|
| Short-Term Debt | 205.06 | 102.6 | 260.19 | 209.81 | 244.17 | 369.18 | Upgrade
|
| Current Portion of Long-Term Debt | 11.56 | 11.96 | 9.51 | 42 | 85.9 | 0.5 | Upgrade
|
| Current Portion of Leases | - | - | 1.15 | 3.38 | 5.07 | 4.43 | Upgrade
|
| Current Income Taxes Payable | 30.09 | 28.11 | 5.64 | 2.66 | 4.83 | 10.87 | Upgrade
|
| Current Unearned Revenue | 15.97 | 22.67 | 33.45 | 20.3 | 42 | 29.35 | Upgrade
|
| Other Current Liabilities | 54.51 | 56.35 | 13.94 | 27.92 | 24.79 | 28.92 | Upgrade
|
| Total Current Liabilities | 569.73 | 484.74 | 576.1 | 576.47 | 759.46 | 1,120 | Upgrade
|
| Long-Term Debt | - | - | 10.79 | 48.69 | 178.39 | 30.32 | Upgrade
|
| Long-Term Leases | 1.02 | 1.19 | 1.17 | 0.25 | 3.07 | 7.45 | Upgrade
|
| Long-Term Unearned Revenue | 43.15 | 50.19 | 43.66 | 49.14 | 60.07 | 58.11 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.88 | 0.9 | 0.71 | 0.85 | 0.8 | 0.04 | Upgrade
|
| Other Long-Term Liabilities | 10.79 | 10.79 | - | - | - | - | Upgrade
|
| Total Liabilities | 625.57 | 547.81 | 632.44 | 675.41 | 1,002 | 1,216 | Upgrade
|
| Common Stock | 380.57 | 380.57 | 369.77 | 370.77 | 371.81 | 371.91 | Upgrade
|
| Additional Paid-In Capital | 886.23 | 873.24 | 812.45 | 818.51 | 830.64 | 821.56 | Upgrade
|
| Retained Earnings | 994.66 | 940.52 | 812.67 | 743.89 | 719.52 | 608.66 | Upgrade
|
| Treasury Stock | -42.88 | -42.88 | - | -7.06 | -14.4 | -18.7 | Upgrade
|
| Comprehensive Income & Other | 84.14 | 82.14 | 46.64 | 57.38 | 96.77 | 29.8 | Upgrade
|
| Total Common Equity | 2,303 | 2,234 | 2,042 | 1,983 | 2,004 | 1,813 | Upgrade
|
| Shareholders' Equity | 2,303 | 2,234 | 2,042 | 1,983 | 2,004 | 1,813 | Upgrade
|
| Total Liabilities & Equity | 2,928 | 2,781 | 2,674 | 2,659 | 3,006 | 3,029 | Upgrade
|
| Total Debt | 217.64 | 115.74 | 282.81 | 304.13 | 516.6 | 411.88 | Upgrade
|
| Net Cash (Debt) | 67.86 | 161.03 | -27.86 | -61.39 | -140.65 | 280.23 | Upgrade
|
| Net Cash Growth | - | - | - | - | - | 17.19% | Upgrade
|
| Net Cash Per Share | 0.18 | 0.44 | -0.08 | -0.17 | -0.38 | 0.75 | Upgrade
|
| Filing Date Shares Outstanding | 386.67 | 352.85 | 369.77 | 370.77 | 371.81 | 371.91 | Upgrade
|
| Total Common Shares Outstanding | 386.67 | 352.85 | 369.77 | 370.77 | 371.81 | 371.91 | Upgrade
|
| Working Capital | 450.98 | 429.56 | 234.12 | 209.39 | 236.32 | 195.05 | Upgrade
|
| Book Value Per Share | 5.96 | 6.33 | 5.52 | 5.35 | 5.39 | 4.88 | Upgrade
|
| Tangible Book Value | 2,189 | 2,119 | 1,924 | 1,862 | 1,879 | 1,684 | Upgrade
|
| Tangible Book Value Per Share | 5.66 | 6.01 | 5.20 | 5.02 | 5.05 | 4.53 | Upgrade
|
| Buildings | - | - | 771.66 | 770.06 | - | - | Upgrade
|
| Machinery | - | - | 1,476 | 1,559 | - | - | Upgrade
|
| Construction In Progress | - | - | 115.74 | 2.57 | 40.48 | 52.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.